denecimig (Mim8) - Hematologic The Deep dive section features an analysis for select pipeline drugs that are expected to be FDA-approved in the upcoming quarters. Selected agents are expected to...

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey

Grant helps provide a home away from home for families facing cancer

In its annual fall report dedicated to oncology, Prime Therapeutics highlights strategies to improve outcomes, reduce costs and support patients — starting with a bold approach to managing cancer care

Prime is committed to simplifying the cancer care journey through leading oncology solutions designed to support people with cancer

Payne to integrate communications, government affairs and policy efforts at leading purpose-driven, transparent PBM

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.

The event emphasizes additional measures for obesity therapy.

Prime Therapeutics experts share more about the latest in precision oncology, including barriers to treatment and the current regulatory landscape

Prime Therapeutics helps simplify the cancer care journey and manage drug costs through leading oncology solutions